Cargando…
Cardiovascular disease prevention: Risk factor modification at the heart of the matter
Autores principales: | Fawzy, Ameenathul M., Lip, Gregory Y.H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8551853/ https://www.ncbi.nlm.nih.gov/pubmed/34734203 http://dx.doi.org/10.1016/j.lanwpc.2021.100291 |
Ejemplares similares
-
Tackling anti-coagulation under-prescription in the elderly
por: Fawzy, Ameenathul M., et al.
Publicado: (2019) -
Endothelial Progenitors and Blood Microparticles: Are They Relevant to Heart Failure With Preserved Ejection Fraction?
por: Shantsila, Eduard, et al.
Publicado: (2016) -
Social determinants of health and cardiovascular outcomes in patients with heart failure
por: Vinter, Nicklas, et al.
Publicado: (2022) -
Incident heart failure, arrhythmias and cardiovascular outcomes with sodium‐glucose cotransporter 2 (SGLT2) inhibitor use in patients with diabetes: Insights from a global federated electronic medical record database
por: Fawzy, Ameenathul Mazaya, et al.
Publicado: (2022) -
Peripheral arterial disease: A high risk – but neglected – disease population
por: Tomson, Joseph, et al.
Publicado: (2005)